Lefamulin-A New Antibiotic for Community-Acquired Pneumonia

被引:13
|
作者
Malani, Preeti N. [1 ]
机构
[1] Univ Michigan, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA
来源
关键词
D O I
10.1001/jama.2019.16215
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1671 / 1672
页数:2
相关论文
共 50 条
  • [1] Lefamulin: A Novel Semisynthetic Pleuromutilin Antibiotic for Community-acquired Bacterial Pneumonia
    Watkins, Richard R.
    File, Thomas M., Jr.
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (10) : 2757 - 2762
  • [2] Treatment of Community-Acquired Pneumonia: A Focus on Lefamulin
    Nathaniel Eraikhuemen
    Daniel Julien
    Alandra Kelly
    Taylor Lindsay
    Dovena Lazaridis
    Infectious Diseases and Therapy, 2021, 10 : 149 - 163
  • [3] Treatment of Community-Acquired Pneumonia: A Focus on Lefamulin
    Eraikhuemen, Nathaniel
    Julien, Daniel
    Kelly, Alandra
    Lindsay, Taylor
    Lazaridis, Dovena
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (01) : 149 - 163
  • [4] Lefamulin (Xenleta) for Community-Acquired Bacterial Pneumonia
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1581): : 145 - 148
  • [5] Lefamulin vs moxifloxacin for community-acquired bacterial pneumonia
    Tang, Hung-Jen
    Wang, Jui-Hsiang
    Lai, Chih-Cheng
    MEDICINE, 2020, 99 (29) : E21223
  • [6] Therapeutic potential of lefamulin in the treatment of community-acquired pneumonia
    Perry, Whitney
    Golan, Yoav
    FUTURE MICROBIOLOGY, 2019, 14 (11) : 927 - 939
  • [8] Lefamulin - upgrading our arsenal against community-acquired pneumonia
    Priyadharshini, Indiraa
    Mohan, Vasanth Konda
    George, Melvin
    ARCHIVES OF PHARMACY PRACTICE, 2020, 11 (03) : 96 - 100
  • [9] Antibiotic stewardship in community-acquired pneumonia
    Viasus, Diego
    Vecino-Moreno, Milly
    De La Hoz, Juan M.
    Carratala, Jordi
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2017, 15 (04) : 351 - 359
  • [10] Antibiotic therapy for community-acquired pneumonia
    Mandell, LA
    CLINICS IN CHEST MEDICINE, 1999, 20 (03) : 589 - +